The purpose of the project is to develop previously inaccessible drug-polymer conjugates with tuneable and sustained drug release rates via a novel polymerisation approach. Ultimately, this will afford next-generation polymer therapeutics suitable for the treatment of a range of disorders and diseases, leading to improvements in heath care.
|Effective start/end date||25/03/13 → 31/12/15|
- Australian Research Council (ARC): AUD152,000.00
- PolyActiva Pty Ltd: AUD53,804.90